|
Quotes & Info
|
| LH > SEC Filings for LH > Form 8-K on 19-Nov-2008 | All Recent SEC Filings |
19-Nov-2008
Regulation FD Disclosure
On November 19, 2008, Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced that it has introduced its MGMT gene methylation assay using Methylation-Specific PCR technology licensed from OncoMethylome Sciences (Euronext Brussels: ONCOB; Euronext Amsterdam: ONCOA). Methylation of the MGMT gene promoter has been shown to be a common event in brain cancers and predictive of response to some therapies.
Exhibits
99.1 Press Release dated November 19, 2008
|
|